Orthobiologics

DiscGenics received approval in Japan to advance into clinical studies of IDCT allogeneic injectible disc cell therapy for the treatment...

Kuros Biosciences was granted FDA 510(k) clearance to market MagnetOs Putty as a standalone bone graft in the extremities and pelvis. ...

Anika Therapeutics resumed global distribution of HYALOFAST and HYALOGRAFT-C therapies for cartilage repair, following a voluntary product recall....

SurGenTec completed initial clinical launch of the GraftGun bone graft delivery system combined with ViBone Viable Bone Matrix prefilled tubes....

BONESUPPORT announced that the CERTiFy study of CERAMENT bone void filler met its primary endpoint of non-inferiority to autologous iliac bone graft in the...

CartiHeal announced successful enrollment of the first patient in the Agili-C IDE pivotal study on the East Coast....

CartiHeal announced a study demonstrating that its Agili-C implant promotes the regenerative capacity of articular cartilage defects in a human cadaveric...

The Data and Safety Monitoring Board recommended discontinuation of the Phase III hip osteonecrosis study of Bone Therapeutics' PREOB viscosupplement,...

CartiHeal has successfully enrolled and treated the 100th patient in the pivotal IDE study of the Agili-C implant. ...

BONESUPPORT commenced direct U.S. sales of bone void filler CERAMENT® BVF. ...